Clinical Trial Update: Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV) [Phase 3]

View source ↗

Summary

Phase 3 trial update on pitolisant (BF2.649) as add-on to sodium oxybate for narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• Pitolisant (BF2.649) (pitolisant)
• Sodium Oxybate (Sodium Oxybate)

Snippet

Sponsor: Bioprojet | Conditions: Narcolepsy | Phase 3 | Status: COMPLETED